Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379089 · ClinicalTrials.gov registry record
Neurologic Manifestations of COVID 19 in Children
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 3,568
- Enrollment target
NCT04379089 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 3,568 participants.
The verdict
NCT04379089 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 3,568 participants
- Enrollment target
Study Summary
The purpose of this study is to perform a secondary analysis of pre-existing de-identified limited datasets obtained from sites participating in Tier 1 (STUDY20040154: Neurologic Manifestations of COVID 19 in Children) and Tier 2 (STUDY20040278: Neuro COVID - Outcomes). The data will be used to determine the prevalence and severity of neurological symptoms among patients requiring critical care admission for confirmed or suspected novel coronavirus (COVID-19) and to determine the predictors for limitation of care in the study population, as well as, the prognosis of neurologically injured patients admitted to the ICU during the COVID-19 crisis. This study is sponsored by the Pediatric Neurocritical Care Research Group (PNCRG) and sponsored and funded in part by the Neurocritical Care Society.
Interventions
- OTHER Observational study only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,568 participants |
| Start Date | 2020-04-29 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04379089
The ClinicalTrials.gov registry entry for NCT04379089 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,568 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational study only is the first listed.
NCT04379089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04379089 about?
NCT04379089 is a clinical study titled "Neurologic Manifestations of COVID 19 in Children". The purpose of this study is to perform a secondary analysis of pre-existing de-identified limited datasets obtained from sites participating in Tier 1 (STUDY20040154: Neurologic Manifestations of COVID 19 in Children) and Tier 2 (STUDY20040278: Neuro COVID - Outcomes). The data will be used to dete...
What is the current status of trial NCT04379089?
This trial is currently completed. The enrollment target is 3,568 participants. The study started on 2020-04-29. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04379089?
The interventions under investigation include: Observational study only (OTHER).
Who is sponsoring clinical trial NCT04379089?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.